How much funding has Alexza Pharmaceuticals raised?

Alexza Pharmaceuticals has raised $124.5M in total funding, most recently a Series D round.

Who are Alexza Pharmaceuticals's investors?

Alexza Pharmaceuticals's investors include Azimuth Opportunity LP, Symphony Capital Partners, Atlas Venture, Wellcome, Abingworth Bioventures, MDS Capital.

When was Alexza Pharmaceuticals founded?

Alexza Pharmaceuticals was founded in 2002.

Where is Alexza Pharmaceuticals headquartered?

Alexza Pharmaceuticals is headquartered in Mountain View, California, United States.

What industry is Alexza Pharmaceuticals in?

Alexza Pharmaceuticals operates in Biotech, Drug Discovery, Healthcare.

How many employees does Alexza Pharmaceuticals have?

Alexza Pharmaceuticals has 51-200 employees.

Alexza Pharmaceuticals

IPO

Alexza.com

Public · Mountain View, United States · Founded 2002 · $124.5M raised

Biotech

Drug Discovery

Healthcare

Headquarters: Mountain View, California
Employees: 51–200
Founded: 2002
Business Model: B2B
Website: alexza.com

Total Funding: $124.5M
Last Round: $20.0M Series DJul 2012
Rounds: 4
Type: Public

About

Founded in 2000 and headquartered in Mountain View, California, Alexza Pharmaceuticals developed and commercialized products based on its proprietary Staccato system — a hand-held single-use inhaler delivering pure drug aerosols to the deep lung for rapid systemic delivery. Its lead commercial product was Adasuve (loxapine), an inhaled antipsychotic for acute agitation associated with schizophrenia or bipolar disorder. Alexza was acquired by Grupo Ferrer Internacional in June 2016 and now operates as part of the Ferrer group.

Summary

Alexza Pharmaceuticals is a Biotech company based in Mountain View, United States, founded in 2002. It has raised $124.5M in total across 4 rounds, most recently a $20.0M Series D round in Jul 2012. Investors include Azimuth Opportunity LP, Symphony Capital Partners and Atlas Venture.